County-Level Variations in Receipt of Surgery for Early-Stage Non-small Cell Lung Cancer in the United States.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
01 2020
Historique:
received: 30 05 2019
revised: 09 09 2019
accepted: 12 09 2019
pubmed: 10 12 2019
medline: 22 7 2020
entrez: 10 12 2019
Statut: ppublish

Résumé

Although counties are the smallest geographic level for comprehensive health-care delivery analysis, little is known about county-level variations in receipt of curative-intent surgery for early-stage non-small cell lung cancer (NSCLC) and factors contributing to such variations in the United States. A total of 179,189 patients aged ≥ 35 years who were diagnosed with stage I to II NSCLC between 2007 and 2014 in 2,263 counties were identified from 39 states, the District of Columbia, and Detroit population-based cancer registries; the data were compiled by the North American Association of Central Cancer Registries. The percentage of patients who underwent surgery was calculated for each county with ≥ 20 cases. Adjusted risk ratios were generated by using generalized estimating equation models with modified Poisson regression. Receipt of surgery for early-stage NSCLC during 2007 to 2014 according to county ranged from 12.8% to 48.6% in the lowest decile of counties, to 74.3% to 91.7% in the highest decile of counties. There were pockets of low surgery receipt rate counties within each state. For example, there was a 25% absolute difference between the lowest and highest surgery receipt rate counties in Massachusetts. Counties in the lowest quartile for receipt of surgery were those with a high proportion of non-Hispanic black subjects, high poverty and uninsured rates, low surgeon-to-population ratio, and nonmetropolitan status. Receipt of curative-intent surgery for early-stage NSCLC varied substantially across counties in the United States, with pockets of low receipt counties in each state. Low surgery receipt counties were characterized by unfavorable area-level socioeconomic and health-care delivery factors.

Sections du résumé

BACKGROUND
Although counties are the smallest geographic level for comprehensive health-care delivery analysis, little is known about county-level variations in receipt of curative-intent surgery for early-stage non-small cell lung cancer (NSCLC) and factors contributing to such variations in the United States.
METHODS
A total of 179,189 patients aged ≥ 35 years who were diagnosed with stage I to II NSCLC between 2007 and 2014 in 2,263 counties were identified from 39 states, the District of Columbia, and Detroit population-based cancer registries; the data were compiled by the North American Association of Central Cancer Registries. The percentage of patients who underwent surgery was calculated for each county with ≥ 20 cases. Adjusted risk ratios were generated by using generalized estimating equation models with modified Poisson regression.
RESULTS
Receipt of surgery for early-stage NSCLC during 2007 to 2014 according to county ranged from 12.8% to 48.6% in the lowest decile of counties, to 74.3% to 91.7% in the highest decile of counties. There were pockets of low surgery receipt rate counties within each state. For example, there was a 25% absolute difference between the lowest and highest surgery receipt rate counties in Massachusetts. Counties in the lowest quartile for receipt of surgery were those with a high proportion of non-Hispanic black subjects, high poverty and uninsured rates, low surgeon-to-population ratio, and nonmetropolitan status.
CONCLUSIONS
Receipt of curative-intent surgery for early-stage NSCLC varied substantially across counties in the United States, with pockets of low receipt counties in each state. Low surgery receipt counties were characterized by unfavorable area-level socioeconomic and health-care delivery factors.

Identifiants

pubmed: 31813533
pii: S0012-3692(19)33944-3
doi: 10.1016/j.chest.2019.09.016
pmc: PMC6965692
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

212-222

Informations de copyright

Copyright © 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Références

Prev Chronic Dis. 2007 Oct;4(4):A111
pubmed: 17875255
Ann Intern Med. 2003 Oct 7;139(7):558-63
pubmed: 14530226
Surg Clin North Am. 2009 Dec;89(6):1359-66, x
pubmed: 19944818
Cancer. 2015 Oct 15;121(20):3564-73
pubmed: 26094729
Med Care. 2008 Jan;46(1):49-57
pubmed: 18162855
Med Care. 1982 Sep;20(9):945-58
pubmed: 7121099
Health Aff (Millwood). 2005 Jul-Aug;24(4):1128-39
pubmed: 16012153
Soc Sci Med. 2003 Jun;56(12):2541-53
pubmed: 12742616
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Health Aff (Millwood). 2012 Aug;31(8):1708-16
pubmed: 22869648
JAMA Surg. 2013 Jul;148(7):589-96
pubmed: 23636896
Cancer. 2005 Apr 15;103(8):1712-8
pubmed: 15768435
Chest. 2000 Jul;118(1):129-37
pubmed: 10893370
JAMA Surg. 2014 Jun;149(6):537-43
pubmed: 24740165
N Engl J Med. 1999 Oct 14;341(16):1198-205
pubmed: 10519898
JAMA. 2017 Jan 24;317(4):388-406
pubmed: 28118455
Bull Am Coll Surg. 2010 Sep;95(9):32-5
pubmed: 21449298
MMWR Morb Mortal Wkly Rep. 2018 Feb 23;67(7):205-211
pubmed: 29470455
Surgery. 2018 Feb;163(2):243-250
pubmed: 29050886
Arch Ophthalmol. 2005 Dec;123(12):1733-8
pubmed: 16344447
JAMA. 2006 May 10;295(18):2141-7
pubmed: 16684984
JAMA. 2010 Jun 16;303(23):2368-76
pubmed: 20551407
J Thorac Oncol. 2016 Jun;11(6):880-9
pubmed: 26980472
Bull Am Coll Surg. 2011 Sep;96(9):38-41
pubmed: 22259933
Ann Thorac Surg. 2005 Dec;80(6):2051-6; discussion 2056
pubmed: 16305843
Health Serv Res. 2013 Aug;48(4):1433-49
pubmed: 23445478
Soc Sci Med. 2017 Feb;175:52-57
pubmed: 28056383
Arch Surg. 2008 Apr;143(4):345-50; discussion 351
pubmed: 18427021
Ann Surg. 2018 Oct;268(4):584-590
pubmed: 30004928
J Public Econ. 2018 Jul;163:99-112
pubmed: 30393411
Health Aff (Millwood). 2007 Sep-Oct;26(5):1459-68
pubmed: 17848458
Health Aff (Millwood). 2017 Jul 26;:
pubmed: 28747321
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Milbank Q. 2006;84(3):521-54
pubmed: 16953809
Inquiry. 2018 Jan-Dec;55:46958018790164
pubmed: 30043655
J Am Coll Surg. 2011 Nov;213(5):633-43
pubmed: 21907598
Ann Intern Med. 2014 May 6;160(9):585-93
pubmed: 24798521
Popul Health Metr. 2013 Jul 10;11:7
pubmed: 23842197
Health Place. 2015 Jul;34:207-14
pubmed: 26086690
Arch Surg. 2005 Jan;140(1):74-9
pubmed: 15655209
Ann Thorac Surg. 2008 Jul;86(1):220-6; discussion 227
pubmed: 18573427
Int J Qual Health Care. 2000 Apr;12(2):133-42
pubmed: 10830670
J Health Hum Serv Adm. 2012 Summer;35(1):11-40
pubmed: 22838054

Auteurs

Helmneh M Sineshaw (HM)

American Cancer Society, Atlanta, GA. Electronic address: helmneh.sineshaw@cancer.org.

Liora Sahar (L)

American Cancer Society, Atlanta, GA.

Raymond U Osarogiagbon (RU)

Baptist Cancer Center, Memphis, TN.

W Dana Flanders (WD)

American Cancer Society, Atlanta, GA; Rollins School of Public Health, Emory University, Atlanta, GA.

K Robin Yabroff (KR)

American Cancer Society, Atlanta, GA.

Ahmedin Jemal (A)

American Cancer Society, Atlanta, GA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH